Anticancer Drugs Olaparib Oncology Pharmacology Physiotherapy

Olaparib (Drug Interactions-1)

In this article we will discuss Olaparib (Drug Interaction-1)

In this article, we will discuss Olaparib (Drug Interactions-1). So, let’s get started.

Anticancer Agents
Clinical studies of Olaparib in combination with other myelosuppressive anticancer agents, including DNA damaging agents, indicate a potentiation and prolongation of myelosuppressive toxicity.

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.